A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease
Titel:
A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease
Auteur:
Aklilu*, M. Hussain, A. Evans, C.P. Hannon, R.A. Lipton, A. Dimairo, M. Yu, J. Zobel, P. Torti, F.M. Finkelman, R.D.